Atlas Trials

A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease

Clinical trial NCT01632462 · UNKNOWN

Trial details

NCT number
NCT01632462
Sponsor
Federico II University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2012-09-01
Primary completion
2014-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.